(Q58862326)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Willemien Beukers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Roy G Masius

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Marcel Vermeij

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ries Kranse

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ellen C Zwarthoff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Geert Jlh van Leenders

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

14 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

515-522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2014.145

22 February 2020

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Quality of life aspects of bladder cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Promoter hypermethylation identifies progression risk in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

T-box genes: what they do and how they do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

DNA methylation-based biomarkers in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.145

Genetic initiation, progression and prognostic markers in transitional cell carcinoma of the bladder: a summary of the structural and transcriptional changes, and the role of developmental genes.

21 January 2018

1 reference

12 December 2020

The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials

1 reference

12 December 2020

TBX2 and TBX3: the special value for anticancer drug targets.

1 reference

12 December 2020

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

1 reference

12 December 2020

Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive.

1 reference

12 December 2020

10.1038/MODPATHOL.2014.145

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394776%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference